Evergreen Capital Management’s West Pharmaceutical WST Stock Holding History

Evergreen Capital Management’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$396K	Buy	1,103 +129	+13%	+$39.4K	0.01%	1044
2026 Q1	$244K	Buy	+974	New	+$242K	0.01%	1268
2023 Q3	–	Sell	-766	Closed	-$293K	–	851
2023 Q2	$293K	Buy	+766	New	+$274K	0.01%	566
2020 Q2	–	Sell	-1,410	Closed	-$215K	–	436
2020 Q1	$215K	Sell	1,410 -3,518	-71%	-$541K	0.02%	321
2019 Q4	$741K	Hold	4,928	–	–	0.06%	194
2019 Q3	$699K	Hold	4,928	–	–	0.07%	185
2019 Q2	$617K	Hold	4,928	–	–	0.06%	201
2019 Q1	$543K	Sell	4,928 -83	-2%	-$8.63K	0.05%	206
2018 Q4	$491K	Buy	5,011 +71	+1%	+$7.7K	0.05%	210
2018 Q3	$610K	Buy	4,940 +37	+0.8%	+$4.15K	0.05%	206
2018 Q2	$487K	Buy	4,903 +56	+1%	+$5.16K	0.05%	219
2018 Q1	$428K	Buy	+4,847	New	+$453K	0.04%	213

Other funds holding WST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Evergreen Capital Management's WST Position: Q2 2026 in Review

Evergreen Capital Management increased its West Pharmaceutical (WST) stake by 13% in Q2 2026, buying an estimated $39.4K and bringing the position to 1,103 shares worth $396K. The position accounts for 0.01% of the portfolio, ranked #1044.

Evergreen Capital Management first reported a position in WST in Q1 2018 and has held it in 12 quarters since. The position peaked at $741K in Q4 2019. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

Evergreen Capital Management held 1,103 shares of West Pharmaceutical worth $396K as of Q2 2026.
Evergreen Capital Management bought 129 West Pharmaceutical shares in Q2 2026, an estimated $39.4K.
West Pharmaceutical made up 0.01% of Evergreen Capital Management's portfolio in Q2 2026, its #1044 holding.
Evergreen Capital Management first reported a position in West Pharmaceutical in Q1 2018 and has held it in 12 quarters since.
Evergreen Capital Management's West Pharmaceutical position peaked at $741K in Q4 2019.
831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Evergreen Capital Management's 13F filing for Q2 2026, filed 23 Jul 2026.